Critical Path Institute to Host 2026 Global Impact Conference on Drug Development in Washington, D.C.
The Critical Path Institute (C-Path) is set to host its 2026 Global Impact Conference (CGIC) in Washington, D.C., from September 15-16, with a special working session on September 17. The conference will take place at the Washington Marriott at Metro Center and aims to address significant challenges in drug development, particularly focusing on how evidence of efficacy and safety is generated and interpreted. The event will bring together leaders from regulatory agencies, the pharmaceutical industry, academia, and advocacy groups, as well as individuals with lived experiences. Keynote speakers include Michael Davis, M.D., Ph.D., acting director of the FDA's Center for Drug Evaluation and Research, and Janet Woodcock, M.D., former principal deputy commissioner of the FDA. The conference will feature plenary panels, targeted workshops, and networking opportunities, all designed to foster collaboration and advance solutions in drug development. 
